Literature DB >> 14616781

Circulating lymphocyte subsets linked to intracellular cytokine profiles in normal humans.

M Matsui1, S Araya, H-Y Wang, N Onai, K Matsushima, T Saida.   

Abstract

To determine whether there is an association between intracellular cytokine profiles and the expression of surface antigens, we performed a simultaneous flow cytometric analysis of these laboratory parameters in 11 healthy volunteers. Peripheral blood lymphocytes were double-stained for CD4 or CD8, as well as CD11a, CD25, CD26, CD29 and CD45RA or the chemokine receptors CCR3, CCR4, CCR5 or CXCR3. Portions of the cell samples were cultured for 4 h in the presence of 1 microm monensin and 20 microg/ml brefeldin A with or without stimulation by phorbol myristate acetate plus ionomycin for the detection of intracellular interferon-gamma (IFN-gamma), interleukin-2 (IL-2), tumour necrosis factor (TNF)-alpha, and IL-4. As a result, CD4+CD29high helper inducer T cells were closely associated with IFN-gamma and TNF-alpha producing CD4+ cells, while CD4+CXCR3+ cells showed a negative correlation with IL-4-producing cells, suggesting that both of these CD4+ subsets consist mainly of Th1 cells. In contrast, CD4+CD45RA+ cells were correlated inversely with IFN-gamma and TNF-alpha-producing cells, and CD8+CD11ahigh killer effector and total CCR5+ cells showed an inverse correlation with IL-2 producing cells, suggesting an immunoregulatory role for these three subsets in non-pathological conditions. Therefore, monitoring of lymphocyte subsets that express functional surface antigens could provide additional information concerning immune deviation, as assessed by the production of Th1/Th2 type cytokines. Further, this type of combined study may provide clues for the pathogenesis of immune-mediated disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14616781      PMCID: PMC1808876          DOI: 10.1046/j.1365-2249.2003.02291.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  44 in total

1.  Increased numbers of CCR5+ interferon-gamma- and tumor necrosis factor-alpha-secreting T lymphocytes in multiple sclerosis patients.

Authors:  T Strunk; S Bubel; B Mascher; P Schlenke; H Kirchner; K P Wandinger
Journal:  Ann Neurol       Date:  2000-02       Impact factor: 10.422

Review 2.  Chemokines and disease.

Authors:  C Gerard; B J Rollins
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

3.  Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire.

Authors:  J J Campbell; S Qin; D Unutmaz; D Soler; K E Murphy; M R Hodge; L Wu; E C Butcher
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

4.  CD4+CD45RA+ and CD4+CD45RA- T cell subsets in man maintain distinct function and CD45RA expression persists on a subpopulation of CD45RA+ cells after activation with Con A.

Authors:  D M Rothstein; S Sohen; J F Daley; S F Schlossman; C Morimoto
Journal:  Cell Immunol       Date:  1990-09       Impact factor: 4.868

5.  Interferon gamma and interleukin 4 producing T cells in peripheral blood of multiple sclerosis patients undergoing immunomodulatory treatment.

Authors:  D Franciotta; E Zardini; R Bergamaschi; L Andreoni; V Cosi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

6.  The isolation and characterization of the human helper inducer T cell subset.

Authors:  C Morimoto; N L Letvin; A W Boyd; M Hagan; H M Brown; M M Kornacki; S F Schlossman
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

7.  Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.

Authors:  A J Schuerwegh; J F van Offel; C H Bridts; W J Stevens; L S De Clerck
Journal:  J Rheumatol       Date:  2001-08       Impact factor: 4.666

8.  Immunological disturbances in the central nervous system linked to MRI findings in multiple sclerosis.

Authors:  Hui Yun Wang; Makoto Matsui; Takahiko Saida
Journal:  J Neuroimmunol       Date:  2002-04       Impact factor: 3.478

9.  The isolation and characterization of the human suppressor inducer T cell subset.

Authors:  C Morimoto; N L Letvin; J A Distaso; W R Aldrich; S F Schlossman
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

10.  Decreased IL-4 producing CD4+ T cells in patients with active systemic lupus erythematosus-relation to IL-12R expression.

Authors:  Kazunori Sugimoto; Shinji Morimoto; Hiroyuki Kaneko; Kazuhisa Nozawa; Yoshiaki Tokano; Yoshinari Takasaki; Hiroshi Hashimoto
Journal:  Autoimmunity       Date:  2002-09       Impact factor: 2.815

View more
  4 in total

1.  Differences in systemic and central nervous system cellular immunity relevant to relapsing-remitting multiple sclerosis.

Authors:  Makoto Matsui; Shin-ichi Araya; Hui-Yun Wang; Kouji Matsushima; Takahiko Saida
Journal:  J Neurol       Date:  2005-03-21       Impact factor: 4.849

2.  NKG2A and CD56 are coexpressed on activated TH2 but not TH1 lymphocytes.

Authors:  Robert J Freishtat; Lindsay W Mitchell; Svetlana D Ghimbovschi; Samuel B Meyers; Eric P Hoffman
Journal:  Hum Immunol       Date:  2006-03-27       Impact factor: 2.850

3.  Intracellular cytokines in peripheral blood leucocytes in children with chronic renal failure.

Authors:  Judi Nairn; Greg Hodge; Paul Henning
Journal:  Pediatr Nephrol       Date:  2005-12-17       Impact factor: 3.714

4.  Tc1/Tc2 ratio in the inflammatory process in patients with Behçet's disease.

Authors:  Habib Houman; Agnes Hamzaoui; Imed Ben Ghorbal; Monia Smiti Khanfir; Moncef Feki; Kamel Hamzaoui
Journal:  Mediators Inflamm       Date:  2004-08       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.